BioSpace News Archive

Business

Progenics Pharmaceuticals Announces Business Update And Third Quarter 2019 Financial Results

Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX) is providing a business update and has today announced financial results for the third quarter 2019.

November 7, 2019
·
21 min read
Business

Biotricity Shows Continued Growth in Core Revenue for Fiscal Q2

Biotricity Inc. (OTCQB: BTCY), a medical diagnostic and consumer healthcare technology company, today announced financial results for its fiscal second quarter ending on September 30, 2019.

November 7, 2019
·
5 min read
Business

IBEX Reports Results for the Year Ended July 31, 2019

IBEX Technologies Inc. reported its financial results for the fiscal year ended July 31, 2019..

November 7, 2019
·
6 min read
Business

CorMedix Inc. to Report Third Quarter 2019 Financial Results and Provide a Corporate Update on November 14

CorMedix Inc. announced that it will report its financial results for the third quarter and nine months ended September 30, 2019, after the market close on Thursday, November 14 and will host a corporate update conference call at 4:30pm Eastern Time.

November 7, 2019
·
1 min read
Business

Xeris Pharmaceuticals Reports Third Quarter 2019 Financial Results and Highlights

Xeris Pharmaceuticals, Inc., a specialty pharmaceutical company leveraging its novel formulation technology platforms to develop and commercialize ready-to-use injectable and infusible drug formulations, announced financial results for the third quarter and nine months ended September 30, 2019.

November 7, 2019
·
8 min read
Genetown

Momenta Pharmaceuticals Announces Poster Presentation at the 61st American Society of Hematology Annual Meeting and Exposition

Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA) today announced that Santiago Arroyo, M.D., Ph.D., Chief Medical Officer, will deliver a poster presentation at the upcoming 61st American Society of Hematology (ASH) Annual Meeting and Exposition being held in Orlando, FL from December 7-10, 2019.

November 7, 2019
·
3 min read
Business

HealthCare.com Secures $18 Million in Series B Funding to Expand Its Health Insurance Technology Solutions

HealthCare.com, the fastest growing leader in technology-enabled health insurance solutions, today announced that it has secured $18 million in Series B funding, which brings the total capital raised to over $27 million.

November 7, 2019
·
3 min read
Deals

FlexEnable Acquires Merck’s OTFT Materials Portfolio for Flexible Displays

FlexEnable, the leader in the development and industrialisation of flexible organic electronics, has acquired Merck’s portfolio of best-in-class, high-performance Organic Thin-Film Transistor (OTFT) materials, including revolutionary and highly-patented organic semiconductors and dielectrics.

November 7, 2019
·
4 min read
Deals

StageBio and Alizée Pathology Merge

StageBio has merged with Alizée Pathology to form the leading provider of specialized histology, pathology, biomarker development, and archiving services for the biopharmaceutical, medical device and contract research industries

November 7, 2019
·
3 min read
BioMidwest

Reminder: Centene Corporation To Host Investor Meeting in NYC On December 13, 2019

Centene Corporation (NYSE: CNC) today issued a reminder that it will host an investor meeting, including a question-and-answer session, on Friday, December 13, 2019

November 7, 2019
·
2 min read